Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion type Assertion NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_head.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion description "[Previously, it was reported that the second ligand-binding domain (LBD II) of megalin is involved in the pathogenesis of passive HN because it is capable of binding antibodies in vivo and initiating formation of immune deposits (ID).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion evidence source_evidence_literature NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion SIO_000772 9727372 NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion wasDerivedFrom befree-20140225 NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.
- NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_assertion wasGeneratedBy ECO_0000203 NP867203.RAyl3-0C7AVnzvp3JVS8OxaiUxDq5ukTzzdSTQbOYkJi8130_provenance.